A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus

Clinical trial NCT00836940 · UNKNOWN

Trial details

NCT number: NCT00836940
Sponsor: Glenmark Pharmaceuticals Europe Ltd. (R&D)
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2008-06-01
Primary completion: 2009-05-01
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.